The Digital Health Breakthrough Network (DHBN) is calling for applications for its fourth class. DHBN is a research incubator that helps startups conduct rapid pilot studies to test their products and move them closer to market.
At this year's Lyfebulb-Novo Nordisk Innovation Summit, Bonbouton won second place and took home $15,000.
For this competition, Patient Entrepreneurs pitch their invention or idea to Lyfebulb founders, Novo Nordisk R&D device leadership, researchers and engineers, and venture capitalists. Contestants respond to a round of Q&A by the judging panel. The top three outstanding Patient Entrepreneurs receive monetary awards to further develop their ideas.
Read more here.
Launchpad Digital Health, a digital health accelerator based in San Francisco, accepts Addicaid into its 12-month startup program. Winners receive up to $500,000 as well as coworking space with other startups.
Read more here.
Applications for the Fall 2017 Class Open through September 15!
Since 2016, the Digital Health Breakthrough Network has helped eight digital healthcare start-ups pilot their products and move them closer to market.
We’re looking for our next class of companies.
Applications are now open to any early stage, New York City-based start-ups based that are developing innovative digital health technologies that address serious marketplace needs.
Selected startups will receive no-cost support to design and conduct rapid pilot studies that test products’ real-world feasibility, design, and commercial potential.
Not only does the program provide immediate benefits for start-ups, it also strengthens New York City’s technology and health sectors.
We’re now reviewing submissions on a rolling basis through Wednesday, September 15. Apply today!
AI-powered assistance for hospitals
Teletherapy and mental health resources for under-served communities
Smart device to monitor medication injections at home
Wearable graphene sensor for detecting and preventing diabetic foot ulcers